Free Fatty Acid-Induced Hypertension in Obese Subjects With Type 2 Diabetes

NCT00738023 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes
Hypertension

Interventions

DRUG: Rosiglitazone
DRUG: Normal saline 0.9%
DRUG: Intralipid 20%

Sponsor

Emory University

Collaborators

[object Object]